Nov-16 -

Radiation Oncology Group

EORTC 22033/26033 – Primary chemotherapy with temozolomide vs. radiotherapy in patients with low grade gliomas after stratification for genetic 1p loss.

A phase III study.

EORTC found that postoperative chemotherapy and radiotherapy were equally as effective in prolonging progression-free survival in patients with low-grade glioma.